Evolent Health Affirms FY2026 Sales Guidance of $2.400B-$2.600B vs $2.487B Est.

Benzinga Newsdesk www.benzinga.com Negative 67.9%

Neg 67.9% Neu 0% Pos 0%

Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.400 billion-$2.600 billion vs $2.487 billion estimate.